![qarc funding qarc funding](https://static.mubasher.info/File.Story_Image/299f173df2e5f010c4359ee70cc98312/640.jpg)
Review the ARC Strategic Plan & NY Program Strategies and consider how your new (or expanding) project supports ARC’s Investment Goals.Ĥ. April 28 th Topic: Collaborative Partnerships - May 5 th Topic: Budgets - May 12 th Topic: Performance Measures - May 19 th Topic: Sustainability Register at: click hereģ.
QARC FUNDING SERIES
The series will run from April 28, 2022, to May 19, 2022, every Thursday at 1pm. In addition to the ARC Area Development Information Sessions, staff will be hosting a virtual Question & Answer series to assist applicants with questions about completing their pre-application. Hosted by Commissioner of Planning and Sustainability, Katie Borgella, of Tompkins County - April 14th, 10am Virtual.Ģ. Hosted by Director of Planning, Elaine Jardine, of Tioga County - April 8th, 10am, Virtual. Hosted by Senior Planner/Lead Supervisor Schoharie County Office of Community Development Services, Shane Nickle, of Schoharie County - April 6th, 11am, Virtual. Hosted by Senior Planner, Tammie Harris, of Otsego County - April 12th, 1pm, In-Person. Hosted by Director of Planning, Shelly Johnson-Bennett, of Delaware County - April 7th, 1pm, Virtual. Hosted by Director of Planning, Trisha Jesset, of Cortland County - April 27th, 6pm, In-Person, at the CCTVS (County/City/Towns/Villages/Schools) group meeting. Hosted by Director of Planning & Airport Administrator, Shane Butler, of Chenango County - April 6th, 1pm, Virtual. Hosted by Director of Planning & Economic Development, Beth Lucas, of Broome County - April 7th, 10am, Virtual. County Planning Directors, in the Southern Tier 8 Region, will be hosting Information Sessions for projects serving their respective county: “In addition to creating new collaborative training models, we are also committed to creating attractive career paths for scientists and engineers beyond their training period to focus on technology development.1.
QARC FUNDING FULL
“At Arc, we want to take full advantage of the ongoing Cambrian explosion in experimental and computational technologies,” said Hsu. In addition, by bringing together the Core Investigator and Technology Center laboratories within Arc headquarters, the institute aims to increase the collision frequency of new ideas and joint projects and make it easy for biologists to work with technology developers to apply advanced tools. An Affiliate Investigator program will support faculty primarily located at Stanford, UC Berkeley, and UCSF. To support both exploratory and long-term research, the institute will hire Arc Core Investigators for renewable eight-year appointments and provide full salary and research support for their laboratories, freeing investigators from the challenges of incessant grant applications and fundraising. Headquartered in the Stanford Research Park in Palo Alto, the institute will pioneer a new model for collaborative research that integrates long-term and unconstrained funding for ambitious science, centers for the rapid development of biotechnologies, and the scientific excellence of world-class research universities. Konermann will serve as the institute’s inaugural director, while Hsu will lead the development of Technology Centers and the Translation Program. Collison, Hsu, and Konermann previously collaborated on Fast Grants, which was launched in early 2020 to provide expedited funding to scientists working on COVID-19-related projects. The Arc Institute has announced its launch as a nonprofit research institution aimed at advancing scientific breakthroughs in complex diseases with investments totaling more than $650 million from founding donors including Stripe co-founder and CEO Patrick Collison.Ĭo-founded by Collison, University of California, Berkeley assistant professor of bioengineering Patrick Hsu, and Stanford University assistant professor of biochemistry Silvana Konermann, the institute will work in collaboration with the two institutions and the University of California, San Francisco on research into diseases including neurodegeneration, cancer, and immune dysfunction.